1science has launched the International Repository of Malaria Research
This repository comprises a carefully selected set of more than 190,000 bibliographic records covering all aspects of research on malaria. 1science has for many years dedicated a great deal of efforts to finding openly accessible versions of scientific papers – and in the case of malaria research, found more than 80,000 of these – all of which can be downloaded directly from the knowledge hub. Visit the malaria research repository here.
For malaria job opportunities check the MalariaWorld Job section.
Global malaria news
Vaccinating humans to protect mosquitoes from malaria: Immunized people would transmit anti-malarial proteins to the insects that bite them, reducing spread of the deadly disease - Science Daily, 9 October
Scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans. This unique approach -- in which immunized humans transfer anti-malarial proteins to mosquitoes when bitten -- is called a transmission-blocking vaccine (TBV). A new biotech advancement moves us closer to this goal. Read the article
Increased cyto-adhesion of malaria parasites during fever uncovered - Science Daily, 9 October
New research shows how the cyto-adhesion of plasmodium-infected red blood cells is enhanced at febrile temperatures. Read the article
Read the latest global malaria news on MalariaWorld.
Read daily malaria news updates here.
Enjoy this week's MalariaWorld - the MW team
This repository comprises a carefully selected set of more than 190,000 bibliographic records covering all aspects of research on malaria.
- Pilot trial shows suppository form of artesunate can slash severe malaria deaths
- Success down to drug formulation, better knowledge of disease also reported
- Large-scale rollout in well-functioning health systems could be ‘ground-breaking’
The French periodical PARIS MATCH published an extensive document on the fight against malaria with Artemisia annua and Artemisia afra. And the dubious role WHO plays.
DELETERIOUS EFFECTS OF ARTEMISIA INFUSIONS ON PARAMECIA, VIBRIO AND PLASMODIUM
For the figures see attached pdf
Jerôme Munyangi,1,University of Kolwezi, Democratic Republic of Congo
Lucile Cornet-Vernet,2, Maisons de l’Artemisia, Paris
Constant Tchandema,3, CAE, Lubumbashi
Pierre Lutgen,4 IFBV-BELHERB, Luxembourg
Progress in malaria elimination across the Asia-Pacific is at critical cross-roads, threatened by the spread of multidrug resistant falciparum malaria and continued transmission among marginalized and mobile populations living and working in conditions beyond the reach of traditional malaria control interventions.
As you probably do, I eagerly check MalariaWorld almost every day, and when I have something to contribute, post a blog or comment. But I am disappointed by the lack of responses to my contributions, or to those from all of you. How can we improve this?
Since almost 10,000 people are connected thru MalariaWorld, we might make real progress if we can all contribute. I want to end malaria sooner, not later. Do you agree?
Amiodarone which is used to control irregular heartbeat also has a protective effect in malaria. It triggers eryptosis and the clearance of malaria infected erythrocytes. In Plasmodium berghei infected mice amiodarone injections increased the survival. It is interesting to note that amiodarone is also active against other tropical diseases like Chagas or Leishmaniasis, both in vitro and in vivo, probably by disrupting the parasites' Ca(2+) homeostasis,
It is valuable and refreshing to see contributions to strategies for malaria suppression in Africa from other disciplines, such as economics. Killeen and Reed pointed out that the portfolio effect cushions mosquito populations and malaria transmission against vector control interventions.(Killeen GF, Reed TE. Malar J. 2018 Aug 10;17(1):291. doi: 10.1186/s12936-018-2441-z.) Thus it must be considered when planning a strategy for Africa.
Vaccines blocking the invasion of malaria sporozoites failed so far, after 30 years of efforts, millions spent, and disastrous human clinical trials. The efforts and the millions are now focused on vaccines blocking transmission by gametocytes. The results are not yet encouraging but the updated Malaria Vaccine Technology Roadmap foresees that there will be a TBV vaccine available in 2030. The update was necessary as the program launched by WHO in 2000 ( TDR/RBM/MAL/VAC/2000.1) has not yet progressed very far.
Published: July 18th 2018
Print ISBN: 978-1-78923-550-0
In 2001 WHO posted a statement on their home page, without signatures, without references: « Due to the instability of artemisinin in raw materials of Artemisia annua L, the leaves need to be stored in cool conditions — preferably below 20°C. Most malaria endemic countries have warm climates and people generally lack access to refrigeration, so it is difficult for patients to keep artemisinin-containing tea bags under 20°C in their homes” A statement not substantiated by scientific papers. Cui bono?
Our associations immediately gathered available data which prove the contrary
“To end malaria there
is need for vision,
people to lead that
vision as seen when
the first person landed
on the moon.”
Don't miss out! Last chance to register!
Join us from 1-5th July 2018 in Melbourne, Australia for this unique multi-sector Congress.
San José / Geneva, 11 June 2018 – The World Health Organization (WHO) today certified Paraguay as having eliminated malaria, the first country in the Americas to be granted this status since Cuba in 1973.
Executive Director of the Global Fund, we're excited to welcome Peter to Melbourne to speak at the 1st Malaria World Congress.
The countdown is on. There's still time to register. Join us from 1-5th July 2018 in Melbourne, Australia and be part of the engaged voices as we aim towards a Roadmap for the Future.
If you are looking for roommates during your stay in Melbourne for the Malaria World Congress, please sign up on conferenceshare.co and search for "Malaria World Congress 2018". You can use the service to connect with each other to facilitate sharing a hotel room, Airbnb, or car rental.
To assist delegates from Low and Lower-Middle Income Countries to participate in the 1st Malaria World Congress, a subsidised registration rate of $350.00 AUD is available.
For detail on eligibility, please check the registration page of the Congress website here.
The Congress program has just been updated so visit the website today to see what we have to offer. Each of the four pillars are equally represented throughout the Congress, with sessions designed to provide the opportunity for discussion.
By integrating the many different facets that make up the response to the scourge of malaria in the one meeting, the 1st Malaria World Congress is utterly unique. Yes, MWC 2018 will feature the latest science, but it will be delivered within the context of the problems in implementing the best tools we have, the difficulties of financing them, and the cultural context of the many communities across the globe that are devastatingly impacted by malaria.
Ostracized for many years by Bigpharma-WHO-Gates, Artemisia and its incredible healing power now becomes a scoop.
See attachments : Le Monde, Jeune Afrique, Le Petit Journal, Sciences&Avenir